Brief: Nugenerex Immuno-Oncology Says Co And Unit Received USD $2 Mln Towards COVID-19 Vaccine Development Initiatives From China Partners
10/02/2021 14:19
Feb 10 (Reuters) - Nugenerex Immuno-Oncology Inc NGIO.O :
* NUGENEREX IMMUNO-ONCOLOGY - ON FEB 8, CO AND UNIT
RECEIVED USD
$2 MILLION TOWARDS ITS COVID-19 VACCINE DEVELOPMENT INITIATIVES
FROM ITS CHINA PARTNERS
Source: https://bit.ly/3a76LeP
Further company coverage: NGIO.O
((Reuters.Briefs@thomsonreuters.com;))